202 related articles for article (PubMed ID: 11364630)
1. Obstacles and progress toward development of a preventive HIV vaccine.
Heyward WL; MacQueen KM; Jaffe HW
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):28-34. PubMed ID: 11364630
[TBL] [Abstract][Full Text] [Related]
2. A safe, effective and affordable HIV vaccine--an urgent global need.
Joseph J; Etcheverry F; Alcami J; María GJ
AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
4. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
5. The immune response to HIV: implications for vaccine development.
Bolognesi DP
Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
[TBL] [Abstract][Full Text] [Related]
6. [The quest for an HIV vaccine].
Girard MP
Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
[TBL] [Abstract][Full Text] [Related]
7. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
8. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
9. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
10. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
11. The development of an AIDS vaccine: progress and promise.
Fauci AS; Fischinger PJ
Public Health Rep; 1988; 103(3):230-6. PubMed ID: 3131812
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
13. Progress and obstacles in the development of an AIDS vaccine.
Letvin NL
Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
15. HIV vaccine development and evaluation: realistic expectations.
Heyward WL; MacQueen KM; Goldenthal KL
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S205-10. PubMed ID: 9814945
[TBL] [Abstract][Full Text] [Related]
16. Vaccine briefing.
Esparza J; Osmanov S
Glob AIDSnews; 1994; (2):5-6. PubMed ID: 12287976
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the development of an effective HIV vaccine: current approaches and future directions.
Klein E; Ho RJ
Clin Ther; 2000 Mar; 22(3):295-314; discussion 265. PubMed ID: 10963285
[TBL] [Abstract][Full Text] [Related]
18. Lessons for AIDS vaccine development from non-AIDS vaccines.
Clements-Mann ML
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
[TBL] [Abstract][Full Text] [Related]
19. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
20. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
WHO/UNAIDS/IAVI International Expert Group
AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
